NCT00123604
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
See it on ClinicalTrials.gov ↗36 people
27.8%
72.2%
10 womenmiddle line = equal numbers26 men
- Phase
- PHASE4
- Paid for by
- St. Paul Heart Clinic
- Finished
- 2006-06
- Health conditions
- Hypertension, Type 2 Diabetes Mellitus
- Who could join
- Anyone
- Ages
- 30 Years – 80 Years
- Average age
- mean 61.4 years
- Age 65+
- 5.6%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Body mass index (BMI) between 22-45 kg/m2”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Clinically significant renal or liver disease (creatinine \>2.5 mg/dL)”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Uncontrollable or symptomatic arrhythmias”
- No diabetes
Women with diabetes were turned away.
“New onset/diagnosed type 2 diabetes (\<3 months)”
- No cancer
Women with current or past cancer were turned away.
“Systemic disease, including cancer, with reduced life expectancy (\<12 months)”
Study titles and rules are shown in their original English.